| The role of the transcription factor EGR1 in cancer B Wang, H Guo, H Yu, Y Chen, H Xu, G Zhao Frontiers in oncology 11, 642547, 2021 | 124 | 2021 |
| The promising role of antibody drug conjugate in cancer therapy: Combining targeting ability with cytotoxicity effectively WQ Li, HF Guo, LY Li, YF Zhang, JW Cui Cancer Medicine 10 (14), 4677-4696, 2021 | 28 | 2021 |
| Advances and challenges in immunotherapy of small cell lung cancer H Guo, L Li, J Cui Chinese Journal of Cancer Research 32 (1), 115, 2020 | 23 | 2020 |
| Research progress and challenges in the treatment of central nervous system metastasis of non-small cell lung cancer B Wang, H Guo, H Xu, H Yu, Y Chen, G Zhao Cells 10 (10), 2620, 2021 | 14 | 2021 |
| The role of graphene oxide nanocarriers in treating gliomas B Wang, H Guo, H Xu, Y Chen, G Zhao, H Yu Frontiers in oncology 12, 736177, 2022 | 13 | 2022 |
| Focused evaluation of the roles of macrophages in chimeric antigen receptor (CAR) T cell therapy associated cytokine release syndrome H Guo, L Qian, J Cui Cancer Biology & Medicine 19 (3), 333, 2022 | 12 | 2022 |
| Advances in combination therapy of immune checkpoint inhibitors for lung cancer GUO Hanfei, BAI Rilan, CUI Jiuwei Zhongguo Fei Ai Za Zhi 23 (2), 2020 | 12 | 2020 |
| Clinical challenges in neoadjuvant immunotherapy for non-small cell lung cancer H Guo, W Li, L Qian, J Cui Chinese Journal of Cancer Research 33 (2), 203, 2021 | 8 | 2021 |
| Coexisting opportunities and challenges: In which scenarios can minimal/measurable residual disease play a role in advanced non-small cell lung cancer? H Guo, W Li, B Wang, N Chen, L Qian, J Cui Chinese Journal of Cancer Research 33 (5), 574, 2021 | 5 | 2021 |
| Precision detection technology: Equipping precision oncology with wings R Bai, Z Lv, X Chen, H Guo, L Bai, H Tian, W Li, J Cui Journal of oncology 2020, 2020 | 5 | 2020 |
| Anaplastic lymphoma kinase-special immunity and immunotherapy Y Guo, H Guo, Y Zhang, J Cui Frontiers in Immunology 13, 908894, 2022 | 4 | 2022 |
| Comprehensive comparison between adjuvant targeted therapy and chemotherapy for EGFR-mutant NSCLC patients: a cost-effectiveness analysis W Li, H Guo, L Li, J Cui Frontiers in Oncology 11, 619376, 2021 | 3 | 2021 |
| Association between visceral fat area and cancer prognosis: a population-based multicenter prospective study L Li, W Li, D Xu, H He, W Yang, H Guo, X Liu, W Ji, C Song, H Xu, W Li, ... The American Journal of Clinical Nutrition 118 (3), 507-517, 2023 | 2 | 2023 |
| Cost-Effectiveness Analyses of Home Parenteral Nutrition for Incurable Gastrointestinal Cancer Patients W Li, H Guo, L Li, J Cui Frontiers in Oncology 12, 858712, 2022 | 2 | 2022 |
| A case of successful pembrolizumab monotherapy in a patient with advanced lung adenocarcinoma: Use of multiple biomarkers in combination for clinical practice H Guo, L Qian, X Chen, Y Zhao, W Song, Y Guan, J Cui Open Medicine 17 (1), 53-60, 2021 | 2 | 2021 |
| Epidermal growth factor receptor compound and concomitant mutations: advances in precision treatment strategies W Li, R Bai, H Guo, J Cui Chinese Medical Journal 136 (23), 2776-2786, 2023 | 1 | 2023 |
| Clonal evolution characteristics and reduced dimension prognostic model for non-metastatic metachronous bilateral breast cancer L Li, J Li, J Jia, H He, M Li, X Yan, Q Yu, H Guo, H Wang, Z Lv, H Sun, ... Frontiers in Oncology 12, 963884, 2022 | 1 | 2022 |
| Molecular classification of small cell lung cancer subtypes: Characteristics, prognostic factors, and clinical translation H Guo, W Li, Y Guo, N Chen, J Cui Chinese Medical Journal 137 (2), 130-139, 2024 | | 2024 |
| Development and validation of a nomogram prognostic model for small cell lung cancer optimized by age and metastatic pattern H Guo, H Tuerxun, W Li, H He, W Yang, Y Bai, Y Li, Y Yang, L Li, J Cui Precision Nutrition 2 (4), e00051, 2023 | | 2023 |
| Current landscape and challenges ahead of immuno-molecular mechanism and immunotherapy strategy of brain metastases H Guo, B Wang, W Li, N Chen, J Cui Holistic Integrative Oncology 2 (1), 31, 2023 | | 2023 |
